The Group's principal activities are supplying systems and offering clinical solutions for effective treatment of severe diseases including cancer, vascular disorders in the brain, and diseases of the central nervous system such as Parkinson's disease and epilepsy. The Group's products include Leksell Gamma Knife, Neuromag Vectorview, Brain Atlas, Leksell Stereotactic System and PreciseSIM. The principal markets for the Group's products are Europe, North America, Japan and the rest of Asia.
Alacra Alerts:
Receive alerts on the latest reports on Elekta AB
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.